8
|
Acharyya S, Villalta SA, Bakkar N, Bupha-Intr T, Janssen PM, Carathers M, Li ZW, Beg AA, Ghosh S, Sahenk Z, Weinstein M, Gardner KL, Rafael-Fortney JA, Karin M, Tidball JG, Baldwin AS, Guttridge DC. Interplay of IKK/NF-kappaB signaling in macrophages and myofibers promotes muscle degeneration in Duchenne muscular dystrophy. J Clin Invest 2007; 117:889-901. [PMID: 17380205 PMCID: PMC1821069 DOI: 10.1172/jci30556] [Citation(s) in RCA: 346] [Impact Index Per Article: 20.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/05/2006] [Accepted: 02/06/2007] [Indexed: 01/25/2023] Open
Abstract
Duchenne muscular dystrophy (DMD) is a lethal X-linked disorder associated with dystrophin deficiency that results in chronic inflammation and severe skeletal muscle degeneration. In DMD mouse models and patients, we find that IkappaB kinase/NF-kappaB (IKK/NF-kappaB) signaling is persistently elevated in immune cells and regenerative muscle fibers. Ablation of 1 allele of the p65 subunit of NF-kappaB was sufficient to improve pathology in mdx mice, a model of DMD. In addition, conditional deletion of IKKbeta in mdx mice elucidated that NF-kappaB functions in activated macrophages to promote inflammation and muscle necrosis and in skeletal muscle fibers to limit regeneration through the inhibition of muscle progenitor cells. Furthermore, specific pharmacological inhibition of IKK resulted in improved pathology and muscle function in mdx mice. Collectively, these results underscore the critical role of NF-kappaB in the progression of muscular dystrophy and suggest the IKK/NF-kappaB signaling pathway as a potential therapeutic target for DMD.
Collapse
Affiliation(s)
- Swarnali Acharyya
- Human Cancer Genetics Program and Department of
Molecular Virology, Immunology and Medical Genetics, The Ohio State University
College of Medicine, Columbus, Ohio, USA. Department of
Physiological Science, UCLA, Los Angeles, California, USA.
Department of Physiology and Cell Biology, The Ohio State University
College of Medicine, Columbus, Ohio, USA. H. Lee Moffitt Cancer
Center and Research Institute, University of South Florida, Tampa, Florida, USA.
Department of Molecular Biophysics and Biochemistry, Yale
University, New Haven, Connecticut, USA. Columbus
Children’s Research Institute, Columbus, Ohio, USA.
Department of Molecular Genetics and Department of
Molecular and Cellular Biochemistry, The Ohio State University College of Medicine,
Columbus, Ohio, USA. Department of Pharmacology, UCSD, San Diego,
California, USA. University of North Carolina at Chapel Hill and
TheraLogics Inc., Research Triangle Park, North Carolina, USA. The
Ohio State University Comprehensive Cancer Center — Arthur G. James
Cancer Hospital and Solove Research Institute, Columbus, Ohio, USA
| | - S. Armando Villalta
- Human Cancer Genetics Program and Department of
Molecular Virology, Immunology and Medical Genetics, The Ohio State University
College of Medicine, Columbus, Ohio, USA. Department of
Physiological Science, UCLA, Los Angeles, California, USA.
Department of Physiology and Cell Biology, The Ohio State University
College of Medicine, Columbus, Ohio, USA. H. Lee Moffitt Cancer
Center and Research Institute, University of South Florida, Tampa, Florida, USA.
Department of Molecular Biophysics and Biochemistry, Yale
University, New Haven, Connecticut, USA. Columbus
Children’s Research Institute, Columbus, Ohio, USA.
Department of Molecular Genetics and Department of
Molecular and Cellular Biochemistry, The Ohio State University College of Medicine,
Columbus, Ohio, USA. Department of Pharmacology, UCSD, San Diego,
California, USA. University of North Carolina at Chapel Hill and
TheraLogics Inc., Research Triangle Park, North Carolina, USA. The
Ohio State University Comprehensive Cancer Center — Arthur G. James
Cancer Hospital and Solove Research Institute, Columbus, Ohio, USA
| | - Nadine Bakkar
- Human Cancer Genetics Program and Department of
Molecular Virology, Immunology and Medical Genetics, The Ohio State University
College of Medicine, Columbus, Ohio, USA. Department of
Physiological Science, UCLA, Los Angeles, California, USA.
Department of Physiology and Cell Biology, The Ohio State University
College of Medicine, Columbus, Ohio, USA. H. Lee Moffitt Cancer
Center and Research Institute, University of South Florida, Tampa, Florida, USA.
Department of Molecular Biophysics and Biochemistry, Yale
University, New Haven, Connecticut, USA. Columbus
Children’s Research Institute, Columbus, Ohio, USA.
Department of Molecular Genetics and Department of
Molecular and Cellular Biochemistry, The Ohio State University College of Medicine,
Columbus, Ohio, USA. Department of Pharmacology, UCSD, San Diego,
California, USA. University of North Carolina at Chapel Hill and
TheraLogics Inc., Research Triangle Park, North Carolina, USA. The
Ohio State University Comprehensive Cancer Center — Arthur G. James
Cancer Hospital and Solove Research Institute, Columbus, Ohio, USA
| | - Tepmanas Bupha-Intr
- Human Cancer Genetics Program and Department of
Molecular Virology, Immunology and Medical Genetics, The Ohio State University
College of Medicine, Columbus, Ohio, USA. Department of
Physiological Science, UCLA, Los Angeles, California, USA.
Department of Physiology and Cell Biology, The Ohio State University
College of Medicine, Columbus, Ohio, USA. H. Lee Moffitt Cancer
Center and Research Institute, University of South Florida, Tampa, Florida, USA.
Department of Molecular Biophysics and Biochemistry, Yale
University, New Haven, Connecticut, USA. Columbus
Children’s Research Institute, Columbus, Ohio, USA.
Department of Molecular Genetics and Department of
Molecular and Cellular Biochemistry, The Ohio State University College of Medicine,
Columbus, Ohio, USA. Department of Pharmacology, UCSD, San Diego,
California, USA. University of North Carolina at Chapel Hill and
TheraLogics Inc., Research Triangle Park, North Carolina, USA. The
Ohio State University Comprehensive Cancer Center — Arthur G. James
Cancer Hospital and Solove Research Institute, Columbus, Ohio, USA
| | - Paul M.L. Janssen
- Human Cancer Genetics Program and Department of
Molecular Virology, Immunology and Medical Genetics, The Ohio State University
College of Medicine, Columbus, Ohio, USA. Department of
Physiological Science, UCLA, Los Angeles, California, USA.
Department of Physiology and Cell Biology, The Ohio State University
College of Medicine, Columbus, Ohio, USA. H. Lee Moffitt Cancer
Center and Research Institute, University of South Florida, Tampa, Florida, USA.
Department of Molecular Biophysics and Biochemistry, Yale
University, New Haven, Connecticut, USA. Columbus
Children’s Research Institute, Columbus, Ohio, USA.
Department of Molecular Genetics and Department of
Molecular and Cellular Biochemistry, The Ohio State University College of Medicine,
Columbus, Ohio, USA. Department of Pharmacology, UCSD, San Diego,
California, USA. University of North Carolina at Chapel Hill and
TheraLogics Inc., Research Triangle Park, North Carolina, USA. The
Ohio State University Comprehensive Cancer Center — Arthur G. James
Cancer Hospital and Solove Research Institute, Columbus, Ohio, USA
| | - Micheal Carathers
- Human Cancer Genetics Program and Department of
Molecular Virology, Immunology and Medical Genetics, The Ohio State University
College of Medicine, Columbus, Ohio, USA. Department of
Physiological Science, UCLA, Los Angeles, California, USA.
Department of Physiology and Cell Biology, The Ohio State University
College of Medicine, Columbus, Ohio, USA. H. Lee Moffitt Cancer
Center and Research Institute, University of South Florida, Tampa, Florida, USA.
Department of Molecular Biophysics and Biochemistry, Yale
University, New Haven, Connecticut, USA. Columbus
Children’s Research Institute, Columbus, Ohio, USA.
Department of Molecular Genetics and Department of
Molecular and Cellular Biochemistry, The Ohio State University College of Medicine,
Columbus, Ohio, USA. Department of Pharmacology, UCSD, San Diego,
California, USA. University of North Carolina at Chapel Hill and
TheraLogics Inc., Research Triangle Park, North Carolina, USA. The
Ohio State University Comprehensive Cancer Center — Arthur G. James
Cancer Hospital and Solove Research Institute, Columbus, Ohio, USA
| | - Zhi-Wei Li
- Human Cancer Genetics Program and Department of
Molecular Virology, Immunology and Medical Genetics, The Ohio State University
College of Medicine, Columbus, Ohio, USA. Department of
Physiological Science, UCLA, Los Angeles, California, USA.
Department of Physiology and Cell Biology, The Ohio State University
College of Medicine, Columbus, Ohio, USA. H. Lee Moffitt Cancer
Center and Research Institute, University of South Florida, Tampa, Florida, USA.
Department of Molecular Biophysics and Biochemistry, Yale
University, New Haven, Connecticut, USA. Columbus
Children’s Research Institute, Columbus, Ohio, USA.
Department of Molecular Genetics and Department of
Molecular and Cellular Biochemistry, The Ohio State University College of Medicine,
Columbus, Ohio, USA. Department of Pharmacology, UCSD, San Diego,
California, USA. University of North Carolina at Chapel Hill and
TheraLogics Inc., Research Triangle Park, North Carolina, USA. The
Ohio State University Comprehensive Cancer Center — Arthur G. James
Cancer Hospital and Solove Research Institute, Columbus, Ohio, USA
| | - Amer A. Beg
- Human Cancer Genetics Program and Department of
Molecular Virology, Immunology and Medical Genetics, The Ohio State University
College of Medicine, Columbus, Ohio, USA. Department of
Physiological Science, UCLA, Los Angeles, California, USA.
Department of Physiology and Cell Biology, The Ohio State University
College of Medicine, Columbus, Ohio, USA. H. Lee Moffitt Cancer
Center and Research Institute, University of South Florida, Tampa, Florida, USA.
Department of Molecular Biophysics and Biochemistry, Yale
University, New Haven, Connecticut, USA. Columbus
Children’s Research Institute, Columbus, Ohio, USA.
Department of Molecular Genetics and Department of
Molecular and Cellular Biochemistry, The Ohio State University College of Medicine,
Columbus, Ohio, USA. Department of Pharmacology, UCSD, San Diego,
California, USA. University of North Carolina at Chapel Hill and
TheraLogics Inc., Research Triangle Park, North Carolina, USA. The
Ohio State University Comprehensive Cancer Center — Arthur G. James
Cancer Hospital and Solove Research Institute, Columbus, Ohio, USA
| | - Sankar Ghosh
- Human Cancer Genetics Program and Department of
Molecular Virology, Immunology and Medical Genetics, The Ohio State University
College of Medicine, Columbus, Ohio, USA. Department of
Physiological Science, UCLA, Los Angeles, California, USA.
Department of Physiology and Cell Biology, The Ohio State University
College of Medicine, Columbus, Ohio, USA. H. Lee Moffitt Cancer
Center and Research Institute, University of South Florida, Tampa, Florida, USA.
Department of Molecular Biophysics and Biochemistry, Yale
University, New Haven, Connecticut, USA. Columbus
Children’s Research Institute, Columbus, Ohio, USA.
Department of Molecular Genetics and Department of
Molecular and Cellular Biochemistry, The Ohio State University College of Medicine,
Columbus, Ohio, USA. Department of Pharmacology, UCSD, San Diego,
California, USA. University of North Carolina at Chapel Hill and
TheraLogics Inc., Research Triangle Park, North Carolina, USA. The
Ohio State University Comprehensive Cancer Center — Arthur G. James
Cancer Hospital and Solove Research Institute, Columbus, Ohio, USA
| | - Zarife Sahenk
- Human Cancer Genetics Program and Department of
Molecular Virology, Immunology and Medical Genetics, The Ohio State University
College of Medicine, Columbus, Ohio, USA. Department of
Physiological Science, UCLA, Los Angeles, California, USA.
Department of Physiology and Cell Biology, The Ohio State University
College of Medicine, Columbus, Ohio, USA. H. Lee Moffitt Cancer
Center and Research Institute, University of South Florida, Tampa, Florida, USA.
Department of Molecular Biophysics and Biochemistry, Yale
University, New Haven, Connecticut, USA. Columbus
Children’s Research Institute, Columbus, Ohio, USA.
Department of Molecular Genetics and Department of
Molecular and Cellular Biochemistry, The Ohio State University College of Medicine,
Columbus, Ohio, USA. Department of Pharmacology, UCSD, San Diego,
California, USA. University of North Carolina at Chapel Hill and
TheraLogics Inc., Research Triangle Park, North Carolina, USA. The
Ohio State University Comprehensive Cancer Center — Arthur G. James
Cancer Hospital and Solove Research Institute, Columbus, Ohio, USA
| | - Michael Weinstein
- Human Cancer Genetics Program and Department of
Molecular Virology, Immunology and Medical Genetics, The Ohio State University
College of Medicine, Columbus, Ohio, USA. Department of
Physiological Science, UCLA, Los Angeles, California, USA.
Department of Physiology and Cell Biology, The Ohio State University
College of Medicine, Columbus, Ohio, USA. H. Lee Moffitt Cancer
Center and Research Institute, University of South Florida, Tampa, Florida, USA.
Department of Molecular Biophysics and Biochemistry, Yale
University, New Haven, Connecticut, USA. Columbus
Children’s Research Institute, Columbus, Ohio, USA.
Department of Molecular Genetics and Department of
Molecular and Cellular Biochemistry, The Ohio State University College of Medicine,
Columbus, Ohio, USA. Department of Pharmacology, UCSD, San Diego,
California, USA. University of North Carolina at Chapel Hill and
TheraLogics Inc., Research Triangle Park, North Carolina, USA. The
Ohio State University Comprehensive Cancer Center — Arthur G. James
Cancer Hospital and Solove Research Institute, Columbus, Ohio, USA
| | - Katherine L. Gardner
- Human Cancer Genetics Program and Department of
Molecular Virology, Immunology and Medical Genetics, The Ohio State University
College of Medicine, Columbus, Ohio, USA. Department of
Physiological Science, UCLA, Los Angeles, California, USA.
Department of Physiology and Cell Biology, The Ohio State University
College of Medicine, Columbus, Ohio, USA. H. Lee Moffitt Cancer
Center and Research Institute, University of South Florida, Tampa, Florida, USA.
Department of Molecular Biophysics and Biochemistry, Yale
University, New Haven, Connecticut, USA. Columbus
Children’s Research Institute, Columbus, Ohio, USA.
Department of Molecular Genetics and Department of
Molecular and Cellular Biochemistry, The Ohio State University College of Medicine,
Columbus, Ohio, USA. Department of Pharmacology, UCSD, San Diego,
California, USA. University of North Carolina at Chapel Hill and
TheraLogics Inc., Research Triangle Park, North Carolina, USA. The
Ohio State University Comprehensive Cancer Center — Arthur G. James
Cancer Hospital and Solove Research Institute, Columbus, Ohio, USA
| | - Jill A. Rafael-Fortney
- Human Cancer Genetics Program and Department of
Molecular Virology, Immunology and Medical Genetics, The Ohio State University
College of Medicine, Columbus, Ohio, USA. Department of
Physiological Science, UCLA, Los Angeles, California, USA.
Department of Physiology and Cell Biology, The Ohio State University
College of Medicine, Columbus, Ohio, USA. H. Lee Moffitt Cancer
Center and Research Institute, University of South Florida, Tampa, Florida, USA.
Department of Molecular Biophysics and Biochemistry, Yale
University, New Haven, Connecticut, USA. Columbus
Children’s Research Institute, Columbus, Ohio, USA.
Department of Molecular Genetics and Department of
Molecular and Cellular Biochemistry, The Ohio State University College of Medicine,
Columbus, Ohio, USA. Department of Pharmacology, UCSD, San Diego,
California, USA. University of North Carolina at Chapel Hill and
TheraLogics Inc., Research Triangle Park, North Carolina, USA. The
Ohio State University Comprehensive Cancer Center — Arthur G. James
Cancer Hospital and Solove Research Institute, Columbus, Ohio, USA
| | - Michael Karin
- Human Cancer Genetics Program and Department of
Molecular Virology, Immunology and Medical Genetics, The Ohio State University
College of Medicine, Columbus, Ohio, USA. Department of
Physiological Science, UCLA, Los Angeles, California, USA.
Department of Physiology and Cell Biology, The Ohio State University
College of Medicine, Columbus, Ohio, USA. H. Lee Moffitt Cancer
Center and Research Institute, University of South Florida, Tampa, Florida, USA.
Department of Molecular Biophysics and Biochemistry, Yale
University, New Haven, Connecticut, USA. Columbus
Children’s Research Institute, Columbus, Ohio, USA.
Department of Molecular Genetics and Department of
Molecular and Cellular Biochemistry, The Ohio State University College of Medicine,
Columbus, Ohio, USA. Department of Pharmacology, UCSD, San Diego,
California, USA. University of North Carolina at Chapel Hill and
TheraLogics Inc., Research Triangle Park, North Carolina, USA. The
Ohio State University Comprehensive Cancer Center — Arthur G. James
Cancer Hospital and Solove Research Institute, Columbus, Ohio, USA
| | - James G. Tidball
- Human Cancer Genetics Program and Department of
Molecular Virology, Immunology and Medical Genetics, The Ohio State University
College of Medicine, Columbus, Ohio, USA. Department of
Physiological Science, UCLA, Los Angeles, California, USA.
Department of Physiology and Cell Biology, The Ohio State University
College of Medicine, Columbus, Ohio, USA. H. Lee Moffitt Cancer
Center and Research Institute, University of South Florida, Tampa, Florida, USA.
Department of Molecular Biophysics and Biochemistry, Yale
University, New Haven, Connecticut, USA. Columbus
Children’s Research Institute, Columbus, Ohio, USA.
Department of Molecular Genetics and Department of
Molecular and Cellular Biochemistry, The Ohio State University College of Medicine,
Columbus, Ohio, USA. Department of Pharmacology, UCSD, San Diego,
California, USA. University of North Carolina at Chapel Hill and
TheraLogics Inc., Research Triangle Park, North Carolina, USA. The
Ohio State University Comprehensive Cancer Center — Arthur G. James
Cancer Hospital and Solove Research Institute, Columbus, Ohio, USA
| | - Albert S. Baldwin
- Human Cancer Genetics Program and Department of
Molecular Virology, Immunology and Medical Genetics, The Ohio State University
College of Medicine, Columbus, Ohio, USA. Department of
Physiological Science, UCLA, Los Angeles, California, USA.
Department of Physiology and Cell Biology, The Ohio State University
College of Medicine, Columbus, Ohio, USA. H. Lee Moffitt Cancer
Center and Research Institute, University of South Florida, Tampa, Florida, USA.
Department of Molecular Biophysics and Biochemistry, Yale
University, New Haven, Connecticut, USA. Columbus
Children’s Research Institute, Columbus, Ohio, USA.
Department of Molecular Genetics and Department of
Molecular and Cellular Biochemistry, The Ohio State University College of Medicine,
Columbus, Ohio, USA. Department of Pharmacology, UCSD, San Diego,
California, USA. University of North Carolina at Chapel Hill and
TheraLogics Inc., Research Triangle Park, North Carolina, USA. The
Ohio State University Comprehensive Cancer Center — Arthur G. James
Cancer Hospital and Solove Research Institute, Columbus, Ohio, USA
| | - Denis C. Guttridge
- Human Cancer Genetics Program and Department of
Molecular Virology, Immunology and Medical Genetics, The Ohio State University
College of Medicine, Columbus, Ohio, USA. Department of
Physiological Science, UCLA, Los Angeles, California, USA.
Department of Physiology and Cell Biology, The Ohio State University
College of Medicine, Columbus, Ohio, USA. H. Lee Moffitt Cancer
Center and Research Institute, University of South Florida, Tampa, Florida, USA.
Department of Molecular Biophysics and Biochemistry, Yale
University, New Haven, Connecticut, USA. Columbus
Children’s Research Institute, Columbus, Ohio, USA.
Department of Molecular Genetics and Department of
Molecular and Cellular Biochemistry, The Ohio State University College of Medicine,
Columbus, Ohio, USA. Department of Pharmacology, UCSD, San Diego,
California, USA. University of North Carolina at Chapel Hill and
TheraLogics Inc., Research Triangle Park, North Carolina, USA. The
Ohio State University Comprehensive Cancer Center — Arthur G. James
Cancer Hospital and Solove Research Institute, Columbus, Ohio, USA
| |
Collapse
|